Search

Your search keyword '"Rees, Aled"' showing total 202 results

Search Constraints

Start Over You searched for: Author "Rees, Aled" Remove constraint Author: "Rees, Aled"
202 results on '"Rees, Aled"'

Search Results

3. Biochemical control with dose reduction in chronic glucocorticoid therapy over 4 years: A phase III extension study of Chronocort (Efmody) in the treatment of Congenital Adrenal Hyperplasia (CAH)

4. CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency

5. Morning cortisol levels in patients with established primary adrenal insufficiency

7. Current utility of first‐line FT4 and TSH in screening for central hypothyroidism.

8. Hormonal control during infancy and testicular adrenal rest tumor development in CAH males - a retrospective multi-center cohort study

9. OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.

12. SAT304 Improved Biochemical Control With Dose Reduction In Chronic Glucocorticoid Therapy: A Phase III Extension Study Of Chronocort (Efmody) In The Treatment Of Congenital Adrenal Hyperplasia (CAH)

15. Switching patients with Congenital Adrenal Hyperplasia to Modified release hydrocortisone capsules: relative bioavailability and disease control

16. The association between hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia

17. Hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia: a retrospective multicenter cohort study

19. RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)

22. Comparison of prednisolone and modified-release hydrocortisone capsules in the treatment of congenital adrenal hyperplasia: dose and disease control

26. Fertility in congenital adrenal hyperplasia (CAH) patients on modified release hydrocortisone capsules (MRHC, Efmody)

27. Improved biochemical control with modified-release hydrocortisone overturns the impaired fludrocortisone effect in salt-wasting CAH patients

28. Modified release hydrocortisone capsules (MRHC, Efmody) improve control of congenital adrenal hyperplasia (CAH) on a lower glucocorticoid dose than standard treatment

29. Clinical/biochemical characteristics of functioning gonadotroph adenomas in women presenting with ovarian hyperstimulation

30. Postradioiodine Graves' management: The PRAGMA study

35. Effectiveness of Metyrapone in Treating Cushingʼs Syndrome: A Retrospective Multicenter Study in 195 Patients

37. Discordant growth hormone and insulin like growth factor-1 values are associated with an increased mortality over concordant normal values in patients treated for acromegaly

38. Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia

41. Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort

44. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs

Catalog

Books, media, physical & digital resources